{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:59:48Z","timestamp":1761663588217,"version":"3.37.3"},"reference-count":23,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2017,6,6]],"date-time":"2017-06-06T00:00:00Z","timestamp":1496707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Medical Virology"],"published-print":{"date-parts":[[2017,9]]},"abstract":"<jats:sec><jats:label\/><jats:p>Information about the use of ombitasvir\/paritaprevir\/ritonavir\/dasabuvir\u2009\u00b1\u2009ribavirin (OBV\/PTV\/r\/DSV\u2009\u00b1\u2009RBV) in real\u2010clinical practice in Latin America is scarce. We aimed to confirm safety and effectiveness of OBV\/PTV\/r\/DSV\u2009\u00b1\u2009RBV therapy in real\u2010world setting. We analyzed a cohort of patients with genotype 1 infection treated with OBV\/PTV\/r\/DSV\u2009\u00b1\u2009RBV. Data on demographics, clinical features, safety, and virological response were retrospectively collected from 21 centers in Latin America. A total of 96 patients received OBV\/PTV\/r\/DSV, associated with RBV in 68% of the cases. Most were genotype 1b (80%), 56 (58%) had cirrhosis, and 45 (47%) failed prior HCV treatment. Adverse events occurred in 62% of patients. The most common adverse events were pruritus (21%), hyperbilirubinemia (17%), and asthenia (17%). Five patients discontinued therapy prematurely due to hepatic decompensation, three of them were Child\u2010Pugh B at baseline and one patient died due to multi\u2010organ failure. Follow up HCV\u2010RNA 12 weeks after completion of therapy was evaluated in all the patients and sustained virologic response rate was 97%. No virologic breakthrough was detected. Our study confirms that OBV\/PTV\/r\/DSV treatment is highly effective in patients with chronic HCV without cirrhosis or with Child\u2010Pugh A cirrhosis in non\u2010European populations. Adverse events were often mild and rarely led to treatment discontinuation except for patients with Child\u2010Pugh B cirrhosis or with previous history of hepatic decompensation. These results can support the development of public strategies to expand the access of OBV\/PTV\/r\u2009+\u2009DSV and other DAAs combinations in order to reduce the burden of HCV infection in our region.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jmv.24816","type":"journal-article","created":{"date-parts":[[2017,3,29]],"date-time":"2017-03-29T12:42:29Z","timestamp":1490791349000},"page":"1590-1596","source":"Crossref","is-referenced-by-count":12,"title":["Ombitasvir\/paritaprevir\/ritonavir\/dasabuvir\u2009\u00b1\u2009ribavirin is safe and effective in HCV\u2010infected patients in a real\u2010life cohort from Latin America"],"prefix":"10.1002","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7026-9908","authenticated-orcid":false,"given":"Manuel","family":"Mendizabal","sequence":"first","affiliation":[{"name":"Unidad de H\u00edgado y Trasplante Hep\u00e1tico Hospital Universitario Austral Pilar Argentina"},{"name":"Latin American Liver Research Educational and Awarness Network (LALREAN)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Haddad","sequence":"additional","affiliation":[{"name":"Secci\u00f3n Hepatolog\u00eda Hospital Italiano de Buenos Aires Buenos Aires Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia E.","family":"Gallardo","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3n Sayani San Salvador de Jujuy Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Ferrada","sequence":"additional","affiliation":[{"name":"Instituto Chileno Japon\u00e9s de Enfermedades Digestivas Hospital San Borja Arriaran Santiago Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro A.","family":"Soza","sequence":"additional","affiliation":[{"name":"Latin American Liver Research Educational and Awarness Network (LALREAN)"},{"name":"Departamento de Gastroenterolog\u00eda Pontificia Universidad Cat\u00f3lica de Chile Santiago Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raul","family":"Adrover","sequence":"additional","affiliation":[{"name":"Latin American Liver Research Educational and Awarness Network (LALREAN)"},{"name":"Unidad de Hepatolog\u00eda Centro de Hepatolog\u00eda La Plata Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmundo","family":"Aravena","sequence":"additional","affiliation":[{"name":"Instituto Chileno Japon\u00e9s de Enfermedades Digestivas Hospital San Borja Arriaran Santiago Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan P.","family":"Roblero","sequence":"additional","affiliation":[{"name":"Instituto Chileno Japon\u00e9s de Enfermedades Digestivas Hospital San Borja Arriaran Santiago Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jhon","family":"Prieto","sequence":"additional","affiliation":[{"name":"Cl\u00ednica Universitaria Colombia y Centro de Enfermedades Hep\u00e1ticas y Digestivas (CEHYD) Bogot\u00e1 Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Vujacich","sequence":"additional","affiliation":[{"name":"Unidad de Hepatitis Virales de FUNCEI Buenos Aires Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Romero","sequence":"additional","affiliation":[{"name":"Secci\u00f3n Hepatolog\u00eda Hospital Dr. Carlos B. Udaondo Buenos Aires Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Mu\u00f1oz","sequence":"additional","affiliation":[{"name":"Secci\u00f3n Hepatolog\u00eda Hospital Dr. Carlos B. Udaondo Buenos Aires Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"Anders","sequence":"additional","affiliation":[{"name":"Unidad de H\u00edgado y Trasplante Hep\u00e1tico Hospital Alem\u00e1n Buenos Aires Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelia","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Cl\u00ednica de Gastroenterolog\u00eda Hospital de Cl\u00ednicas Montevideo Uruguay"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Coccozella","sequence":"additional","affiliation":[{"name":"Latin American Liver Research Educational and Awarness Network (LALREAN)"},{"name":"Unidad de Hepatolog\u00eda Centro de Hepatolog\u00eda La Plata Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Gruz","sequence":"additional","affiliation":[{"name":"Hepatolog\u00eda y Trasplante Hep\u00e1tico Hospital Universitario Fundaci\u00f3n Favaloro Buenos Aires Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria V.","family":"Reggiardo","sequence":"additional","affiliation":[{"name":"Latin American Liver Research Educational and Awarness Network (LALREAN)"},{"name":"Secci\u00f3n Hepatolog\u00eda Hospital del Centenario Rosario Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andres E.","family":"Ruf","sequence":"additional","affiliation":[{"name":"FUNDIEH y HPR\u2010Grupo Gamma Rosario Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Var\u00f3n","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3n Cardioinfantil Instituto de Cardiolog\u00eda Bogot\u00e1 Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano","family":"Cartier","sequence":"additional","affiliation":[{"name":"Secci\u00f3n Hepatolog\u00eda Hospital Dr. Carlos B. Udaondo Buenos Aires Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"P\u00e9rez Ravier","sequence":"additional","affiliation":[{"name":"Trasplante Hep\u00e1tico Hospital Italiano de Mendoza Mendoza Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezequiel","family":"Ridruejo","sequence":"additional","affiliation":[{"name":"Unidad de H\u00edgado y Trasplante Hep\u00e1tico Hospital Universitario Austral Pilar Argentina"},{"name":"Latin American Liver Research Educational and Awarness Network (LALREAN)"},{"name":"CEMIC Buenos Aires Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirta","family":"Peralta","sequence":"additional","affiliation":[{"name":"Unidad de H\u00edgado Hospital Francisco J. Mu\u00f1iz Buenos Aires Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Poncino","sequence":"additional","affiliation":[{"name":"Secci\u00f3n Hepatolog\u00eda Sanatorio Municipal Dr. Julio M\u00e9ndez Buenos Aires Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Vorobioff","sequence":"additional","affiliation":[{"name":"Universidad Nacional de Rosario Rosario Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Aballay Soteras","sequence":"additional","affiliation":[{"name":"Sanatorio Mitre Buenos Aires Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo O.","family":"Silva","sequence":"additional","affiliation":[{"name":"Unidad de H\u00edgado y Trasplante Hep\u00e1tico Hospital Universitario Austral Pilar Argentina"},{"name":"Latin American Liver Research Educational and Awarness Network (LALREAN)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,6,6]]},"reference":[{"doi-asserted-by":"publisher","key":"e_1_2_6_2_1","DOI":"10.1111\/j.1478-3231.2011.02538.x"},{"doi-asserted-by":"publisher","key":"e_1_2_6_3_1","DOI":"10.1053\/j.gastro.2008.02.069"},{"key":"e_1_2_6_4_1","article-title":"Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non\u2010responders to pegylated interferon and ribavirin and treatment\u2010naive patients: the COSMOS randomised study","author":"Lawitz E","year":"2014","journal-title":"Lancet"},{"doi-asserted-by":"publisher","key":"e_1_2_6_5_1","DOI":"10.1056\/NEJMoa1402869"},{"doi-asserted-by":"publisher","key":"e_1_2_6_6_1","DOI":"10.1002\/hep.28446"},{"doi-asserted-by":"publisher","key":"e_1_2_6_7_1","DOI":"10.1056\/NEJMoa1315722"},{"doi-asserted-by":"publisher","key":"e_1_2_6_8_1","DOI":"10.1016\/j.jhep.2015.10.005"},{"doi-asserted-by":"publisher","key":"e_1_2_6_9_1","DOI":"10.1056\/NEJMoa1402338"},{"doi-asserted-by":"publisher","key":"e_1_2_6_10_1","DOI":"10.1177\/1060028016659306"},{"doi-asserted-by":"publisher","key":"e_1_2_6_11_1","DOI":"10.1111\/apt.13790"},{"doi-asserted-by":"publisher","key":"e_1_2_6_12_1","DOI":"10.1038\/ajg.2009.173"},{"doi-asserted-by":"publisher","key":"e_1_2_6_13_1","DOI":"10.1002\/hep.1840200104"},{"unstructured":"http:\/\/www.hcvguidelines.org\/full-report\/. Access October 2016.","key":"e_1_2_6_14_1"},{"doi-asserted-by":"publisher","key":"e_1_2_6_15_1","DOI":"10.1001\/jamaoncol.2015.2639"},{"doi-asserted-by":"publisher","key":"e_1_2_6_16_1","DOI":"10.1056\/NEJMoa1401561"},{"doi-asserted-by":"publisher","key":"e_1_2_6_17_1","DOI":"10.1056\/NEJMoa1408921"},{"doi-asserted-by":"publisher","key":"e_1_2_6_18_1","DOI":"10.1053\/j.gastro.2016.02.078"},{"doi-asserted-by":"publisher","key":"e_1_2_6_19_1","DOI":"10.1001\/jama.2015.1328"},{"doi-asserted-by":"publisher","key":"e_1_2_6_20_1","DOI":"10.1016\/j.jhep.2016.09.001"},{"unstructured":"http:\/\/www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/SafetyAlertsforHumanMedicalProducts\/ucm468757.htm.","key":"e_1_2_6_21_1"},{"key":"e_1_2_6_22_1","first-page":"528A","article-title":"Ombitasvir\/paritaprevir\/r and dasabuvir with ribavirin for HCV genotype 1 patients with decompensated cirrhosis","volume":"62","author":"Mantry PS","year":"2015","journal-title":"Hepatology (Baltimore, Md)"},{"doi-asserted-by":"publisher","key":"e_1_2_6_23_1","DOI":"10.1056\/NEJMp1400160"},{"key":"e_1_2_6_24_1","first-page":"992","article-title":"Prevalence of pre\u2010existing Hepatitis C variants resistant to protease inhibitors in patients infected with HCV genotype 1","volume":"15","author":"Martinez AP","year":"2016","journal-title":"Ann Hepatol"}],"container-title":["Journal of Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjmv.24816","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jmv.24816","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T23:32:38Z","timestamp":1696375958000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jmv.24816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,6]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["10.1002\/jmv.24816"],"URL":"https:\/\/doi.org\/10.1002\/jmv.24816","archive":["Portico"],"relation":{},"ISSN":["0146-6615","1096-9071"],"issn-type":[{"type":"print","value":"0146-6615"},{"type":"electronic","value":"1096-9071"}],"subject":[],"published":{"date-parts":[[2017,6,6]]}}}